Abstract

Because of the differences of treatment, it is extremely important to classify the types of diabetes, especially for the diagnosis made by clinician. In this study, we proposed a novel scheme calculating an indicator of classifying diabetes, which contains two stages: the first is a model of feature extraction, 17 features are automatically extracted from the curve of glucose concentration acquired by continuous glucose monitoring system (CGM); the second is a model of diabetes parameter regression based on an ensemble learning algorithm named double-Class AdaBoost. 1050 curves of glucose concentration of type 1 and type 2 diabetics were acquired at the Department of Endocrinology in People’s Hospital of Zhengzhou University China, and an upper threshold μ was set to 7 mmol/L, 8 mmol/L, 9 mmol/L, 10 mmo/L, and 11 mmol/L respectively according to the guideline of WHO. The experiments show that the coincidence rate of our scheme and clinical diagnosis is 90.3%. The novel indicator extends the criteria in diagnosing types of diabetes and provides doctors with a scalar to classify diabetes of type 1 and type 2.

Details

Title
A Novel Classification Indicator of Type 1 and Type 2 Diabetes in China
Author
Wang, Yannian 1 ; Liu, Shanshan 1 ; Chen, Ruoxi 1 ; Chen, Zhongning 2 ; Yuan, Jinlei 3 ; Li, Quanzhong 4 

 School of Information Engineering, Zhengzhou University, Zhengzhou, Henan, P.R. China 
 Department of Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA 
 The Fifth Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, P.R. China 
 Department of Endocrinology, People’s Hospital of Zhengzhou University, Zhengzhou, Henan, P.R. China 
Pages
1-7
Publication year
2017
Publication date
Dec 2017
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1983429754
Copyright
© 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.